To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Weight-adjusted dosing of… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection.

Journal article
Authors Martin Lagging
Nina Langeland
Court Pedersen
Martti Färkkilä
Mads Rauning Buhl
Kristine Mørch
Amar P Dhillon
Åsa Alsiö
Kristoffer Hellstrand
Johan Westin
Peer Christensen
Peter Leutscher
Gunnar Norkrans
Published in Hepatology (Baltimore, Md.)
Volume 48
Issue 2
Pages 695
ISSN 1527-3350
Publication year 2008
Published at Institute of Biomedicine, Department of Infectious Medicine
Pages 695
Language en
Links dx.doi.org/10.1002/hep.22450
Keywords Antiviral Agents, administration & dosage, therapeutic use, Body Weight, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Therapy, Combination, Genotype, Hepacivirus, genetics, Hepatitis C, Chronic, blood, drug therapy, pathology, Humans, Interferon Alfa-2a, administration & dosage, therapeutic use, Polyethylene Glycols, administration & dosage, therapeutic use, RNA, Viral, blood, Ribavirin, administration & dosage, therapeutic use, Time Factors
Subject categories Microbiology in the medical area
Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?